Commentary: Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial
Open Access
- 6 March 2018
- journal article
- editorial
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 10, 54
Abstract
Commentary: Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled TrialKeywords
This publication has 10 references indexed in Scilit:
- Impact of a Pilot, Pharmacy-Led Tobacco Cessation Medication Protocol at Discharge in a Community HospitalJournal of Pharmacy and Pharmacology, 2017
- Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderlyNeurobiology of Aging, 2017
- Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled TrialFrontiers in Aging Neuroscience, 2016
- Nutritional Cognitive Neuroscience: Innovations for Healthy Brain AgingFrontiers in Neuroscience, 2016
- Elevated fecal calprotectin in patients with Alzheimer’s dementia indicates leaky gutJournal of Neural Transmission, 2015
- α 1-antitrypsin modulates microglial-mediated neuroinflammation and protects microglial cells from amyloid-β-induced toxicityJournal of Neuroinflammation, 2014
- Cognitive decline, dietary factors and gut–brain interactionsMechanisms of Ageing and Development, 2014
- Immune activation in patients with Alzheimer's disease is associated with high serum phenylalanine concentrationsJournal of the Neurological Sciences, 2013
- Inflammatory S100A9 and S100A12 proteins in Alzheimer's diseaseNeurobiology of Aging, 2006
- Tryptophan degradation and immune activation in Alzheimer's diseaseJournal of Neural Transmission, 2000